Product custom-nanocomposites-fluorescent-labeled-nanocomposites

Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites

Catalog	name	Description	price
R-Mcs-250	DOPS:DOPC:Chol:DPPE-N-(6-azidohexanoyl) (ammonium salt)-Cyanine 5 lipid-Azide	DOPS:DOPC:Chol:DPPE-N-(6-azidohexanoyl) (ammonium salt)(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 5 lipid-Azide can be utilized for in vivo or in vitro imaging studies, enabling tracking of liposomes and associated compounds using fluorescence microscopy or other imaging techniques.The targeted delivery of drugs or other therapeutic agents can be enhanced through the use of DOPS and the bioorthogonal azide functionality for selective targeting.	price>
R-Mcs-251	DOPS:DOPC:Chol:DPPE-N-(6-azidohexanoyl) (ammonium salt)-Cyanine 5.5 lipid-Azide	DOPS:DOPC:Chol:DPPE-N-(6-azidohexanoyl) (ammonium salt)(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 5.5 lipid-Azide can be effectively utilized in various biomedical applications, including imaging and drug delivery. The unique fluorescent properties can be utilized for live-cell imaging, allowing researchers to track liposome distribution and dynamics in real-time. The enhanced azide functionality can enable targeted delivery of therapeutic agents through bioorthogonal reactions. Use in fluorescent assays for disease diagnostics, particularly in targeted detection of biomarkers.	price>
R-Mcs-252	DOPS:DOPC:Chol:DPPE-N-(6-azidohexanoyl) (ammonium salt)-Cyanine 7 lipid-Azide	DOPS:DOPC:Chol:DPPE-N-(6-azidohexanoyl) (ammonium salt)(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 7 lipid-Azide can be utilized for various cutting-edge applications in biological research, targeting, and imaging. The use of Cyanine 7, with its advantageous optical properties in the near-infrared spectrum, allows deep tissue imaging and tracking of liposome behavior in biological systems. Utilizing the azide functionality allows for bioorthogonal click chemistry reactions, which can enable the targeting of drugs or therapeutic agents to specific cells or tissues. Fluorescent Probes for Diagnostics: These liposomes can be employed in diagnostic assays, enabling sensitive detection of biological markers through fluorescence.	price>
R-Mcs-253	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiA-DBCO	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiA-DBCO is a sophisticated system potentially used in biomedical research or clinical applications, especially in the realms of targeted therapeutics or imaging. The DBCO moieties can be used to chemically conjugate therapeutic agents or targeting ligands (e.g., antibodies) to the liposomes, enhancing specificity for certain cell types or tissues. The incorporation of DiA enables visual tracking of liposomes in biological systems, useful for studying biodistribution, therapeutic efficacy, or cellular uptake.	price>
R-Mcs-254	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiD-DBCO	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiD-DBCO can be used for basic research to investigate cellular processes, drug interactions, and therapeutic outcomes as they can be tracked and monitored via fluorescence. The formulation could also be adapted for vaccine delivery, using the liposomes to encapsulate antigens and enhance their immunogenicity. This formulation can be engineered to attach various drugs or targeting moieties (such as antibodies or peptides) to liposomes via the DBCO reaction. This can enhance the specificity of drug delivery to target cells or tissues. DiD provides a way to visually track the liposomes within biological systems, making this formulation useful for studying biodistribution, cellular uptake, and therapeutic efficacy.	price>
R-Mcs-255	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiI-DBCO	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiI-DBCO can be adapted for the delivery of genetic materials, taking advantage of ability of DOPE to facilitate membrane fusion, which is crucial for effective transfection. The DBCO moiety allows for the attachment of targeting ligands (e.g antibodies, peptides) to the liposomes, enhancing delivery specificity to target cells or tissues (such as cancer cells). Using DiI as a fluorescent marker, these liposomes can be tracked in vitro or in vivo. Researchers can visualize biodistribution, cellular uptake, and the overall pharmacokinetics of the liposomes.	price>
R-Mcs-256	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiO-DBCO	The L-alpha-PC:Chol:DOPE-N-DBCO (69:30:1 molar ratio) - Neutral Fluoroliposome DiO-DBCO formulation represents a versatile and innovative liposomal system suitable for a range of biotechnological and pharmaceutical applications. The combination of neutral charge, bioorthogonal chemistry, and fluorescent labeling allows for significant flexibility in tailoring the liposomes for specific roles in research and clinical applications.	price>
R-Mcs-257	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiR-DBCO	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiR-DBCO can be used in vaccine delivery systems, where they encapsulate antigens and help in inducing immune responses. The liposomes can encapsulate therapeutic agents, improving their solubility, stability, and bioavailability. The lipid composition supports effective delivery through biological barriers.The incorporation of fluorophores like DiR allows for non-invasive imaging in vivo. This is beneficial for studying the pharmacokinetics of liposomal formulations and their targeting to specific tissues or tumors.The bioorthogonal chemistry enabled by N-DBCO allows for precise functionalization of the liposomes with targeting ligands (e.g., antibodies, peptides) that can bind to specific cell types or disease markers. This enhances the efficacy and reduces the side effects of therapeutic agents.	price>
R-Mcs-258	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome Dansyl lipid (headgroup)-DBCO	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome Dansyl lipid (headgroup)-DBCO can be designed for vaccine delivery, wherein they can encapsulate antigens and adjuvants, potentially enhancing the immunogenic response. L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome Dansyl lipid (headgroup)-DBCO serves as a platform for studying pharmacokinetics, therapeutic efficacy, and the safety of liposomal systems in clinical applications. These liposomes can encapsulate various therapeutic agents (chemotherapeutics, peptides, nucleic acids) and facilitate their delivery to target sites, improving efficacy and reducing side effects.Utilizing the fluorescent properties of the dansyl group, researchers can visualize and track liposomes in living organisms, assessing their biodistribution and cellular uptake mechanisms.The presence of DBCO allows for the conjugation of azide-functionalized compounds, such as targeting ligands or therapeutic agents. This feature is particularly useful in creating custom-targeted liposomes for specific applications.Dansyl lipids can be used to study lipid interactions and dynamics in membranes, providing insights into membrane fluidity, phase behavior, and interactions with proteins or drugs.	price>
R-Mcs-259	L-alpha-PC:Chol:DOPE-N-DBCO-Neutral Fluoroliposome NBD lipid (fatty acid tail)-DBCO	L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome NBD lipid (fatty acid tail)-DBCO serves as a platform for studying pharmacokinetics, therapeutic efficacy, and the safety of liposomal systems in clinical applications. These liposomes can encapsulate various therapeutic agents (chemotherapeutics, peptides, nucleic acids) and facilitate their delivery to target sites, improving efficacy and reducing side effects.Utilizing the fluorescent properties of the dansyl group, researchers can visualize and track liposomes in living organisms, assessing their biodistribution and cellular uptake mechanisms.The presence of DBCO allows for the conjugation of azide-functionalized compounds, such as targeting ligands or therapeutic agents. This feature is particularly useful in creating custom-targeted liposomes for specific applications.	price>

...